Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 13

ОБЗОР2026 · pp. 79–86

Molecular mechanisms, pharmacological properties, and applications of PARP inhibitors in ovarian cancer therapy

Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …

10.29296/24999490-2026-03-11Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56

Comparative analysis of Hsp27 and Hsp90 expression in high- and low-grade ovarian carcinoma cells

Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…

10.29296/24999490-2026-02-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

THE ROLE OF SWI/SNF CHROMATIN REMODELER COMPOSITION IN SENSITIVITY TO GSK126 AND ABT263

Introduction. Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer characterized by frequent mutations in the ARID1A gene and low sensitivity to standard-of-care chemotherapeutic agents. The aim of the study. To determine the role of A…

10.29296/24999490-2020-01-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019

ACTIVATING POINT MUTATION OF BRCA1/2 GENES IN AZERBAIJAN POPULATION

Introduction. Breast cancer is the leading cancer type among woman of Azerbaijan population. Hereditary mutations of the BRCA1/2 genes are considered as high risk for appeared breast and ovarian cancers. In Azerbaijan BRCA1/2-related breast and ovarian cancer …

10.29296/24999490-2019-02-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

MOLECULAR AND CELLULAR FACTORS OF LOCAL IMMUNITY IN ASCITIC FLUID OF OVARIAN CANCER PATIENTS

Introduction. Immunologic microenvironment of malignant tumors is likely to be significant in «tumor-host» interaction. The aim of the study. Сomparative analysis of systemic and local factors of cellular and humoral immunity in patients with ascitic forms of …

Details ↗
ОБЗОР2016

MICRORNAS AS BIOLOGICAL MARKERS OF OVARIAN CANCER

MicroRNAs (miRNAs) – small non-coding RNAs targeting multiple mRNAs – are posttranscriptional regulators of gene expression involved in carcinogenesis, metastasis, and invasion. MiRNAs expression is altered in various human tumors including ovarian cancer. Ana…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

THE INSULINE-LIKE GROWTH FACTOR SYSTEM IN OVARIAN CANCER METASTASIS: THE RELATION WITH P45 SER Β-CATENIN

Introduction: Insulin-like growth factors (IGFs), insulin-like growth factor-I receptor (IGF-IR), IGR-binding proteins (IGFBPs) and IGBP proteases can play an important role in the development of metastases in ovarian cancer. The relationship between IGF syste…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

MICRORNAS IN ONCOLOGICAL DISEASES

The most important event in the molecular biology of the last years is the discovery of the regulation of intracellular processes by micro RNAs – a product of complicated processing of precursor RNAs synthesized on nuclear genes, that are playing the key role …

Details ↗
Research article2014

INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF BINDING PROTEINS IN BLOOD SERUM AND TUMORS OF OVARIAN TUMOR PATIENTS

Introduction. Insulin-like growth factor signaling system plays a major role in the development and progression of various malignant tumors including ovarian cancer, and its components are considered as potential diagnostic and prognostic markers and objects o…

Details ↗
Research article2013

ENDOTHELIAL GROWTH FACTOR AND ITS RECEPTORS IN OVARIAN CANCER

A literature review is devoted to the analysis of clinical significance of key factors of neoangiogenesis in ovarian cancer patients, their connection with the main clinical and morphological characteristics of the disease, prognosis, features an anti-angiogen…

Details ↗ PDF
Research article2013

ANALYSIS OF GENETIC POLYMORPHISMS IN ESTROGENMETABOLIZING ENZYMES IN OVARIAN CANCER PATIENTS IN THE SIBERIA REGION

Early diagnosis of ovarian cancer (OC) remains to be the actual problem in modern oncology due to the high mortality rate, asymptomatic course of the disease in the early stages and its aggressiveness. The aim was to study the genetic polymorphism of pathogene…

Details ↗ PDF

Article search and quick navigation

Navigation